Prevalence of elevated Lipoprotein (a) among young and middle-aged patients with acute coronary syndrome and its correlation with angiographic findings at Sulaimani Cardiac Hospital
DOI:
https://doi.org/10.56056/Keywords:
Acute coronary syndrome, Coronary angiography, Lipoprotein (a), SYNTAX scoreAbstract
Background and objectives: The relation of elevated lipoprotein (a) to severity of coronary artery disease is still debatable. This study was conducted to show the correlation between high levels of Lipoprotein (a) and severity of coronary artery disease.
Methods: This was a prospective longitudinal study, conducted at Sulaimani Cardiac Hospital in Sulaimani-Iraq, from March/2024 to June/2024. The sample consisted of 150 cases of acute coronary syndrome. The blood was sent for lipid profile, and patients were taken to the catheterization lab for further management. SYNTAX score was calculated to determine the correlation between coronary artery disease severity and SYNTAX score.
Results: Out of 150 participants, 115(76.7%) were males and 35(23.3%) were females. The mean age was 51.6±7.193, ranging from 25 to 59 years. There was a significant positive correlation between Lp (a) ? 126 nmol/L and SYNTAX score ( p < o.oo1).Overall,30.6% of the cases (n= 46, 38 males and 8 females) had abnormal Lp (a) results ( more than 75 nmol/L).Patients with highest lipoprotein(a) were more likely to be older (mean age = 56,27±5.22 , p = 0.03 ).There was a positive correlation between cases with positive family history and elevated lipoprotein(a)( p = 0.012).No statistically significant correlation was established among other risk factors( Diabetes, hypertension, smoking , lifestyle , previous angiography, ethnicity , and body mass index) and lipoprotein( a ) level.
Conclusion: There was a statistically significant positive correlation between elevated Lp (a) and severity of coronary lesions assessed by SYNTAX score.
Downloads
References
1. Libby P, Buring JE, Badimon L. Atherosclerosis. Nat Rev Dis Prim. 2019;5(1):1-18.
2. Leistner DM, Laguna-F A, Haghikia A, Abdelwahid S, Sophie A, Erbay A, et al. Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity. Eur J Prev Cardiol. 2024:11;31(7):856-865.
3. Tsimikas S, Marcovina SM. Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;80(9):934-946.
4. Na Xu, Xiao-F, Yi Y, Si-da, Yue L, Xue-Y, et al. Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention. Nutr Metab Cardiovasc Dis. 2020;30(2):265-273.
5. Zhang H, Zhao X, Guo YL, Gao Y, Zhu CG, Li J, et al. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2018;28(10):980-986.
6. Nordestgaard BG, Langsted A. Lipoprotein (a) as a cause of cardiovascular disease: Insights from epidemiology, genetics, and biology. J Lipid Res. 2016;57(11):1953-1975.
7. Balakrishnan V, Sankaran R, Thanikachalam S, Muralidharan T., Nagendra B, Bhavidra R, et al.Relevance of Syntax Score as a Marker of Complex Coronary Artery Disease and Plaque Burden in Young Coronary Artery Disease - A Single Centre Multifactorial Analysis. J Evol Med Dent Sci. 2019;8(40):3039-3043.
8. Abdelrazik M,Sawy EL, Ahmed M, Fouad R. Correlation between Dyslipidiemia and the Severity of Coronary Artery Disease Using SYNTAX Scoring System. Egypt J Hosp Med. 2017; 66:52-56.
9. Yang C-H, Hsieh M-J, Chen C-C, Shang-H, Chao-Y, Cheng-H et al. SYNTAX score: an independent predictor of long-term cardiac mortality. Coronary Artery Dis journal. 2012;23(7):445-449.
10. Xu W, Guan H, Gao D, Zicheng W, Yanna Ba, Hao, et al. The association of syntax score with levels of lipoprotein(A) and inflammatory biomarkers in patients with stable coronary artery disease and different low-density lipoprotein cholesterol levels. Diabetes, Metab Syndr Obes. 2020; 13:4297-4310.
11. Farnier M, Chagué F, Maza M, Florence B, David M, Yves C, et al. High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey. J Clin Lipidol. 2022;16(5):685-693.
12. Bhandari G, Rajadhyaksha G, Shah M. To Assess Relationship of Lipoprotein (a) with Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction: A Hospital based Cross-sectional Study. J Clin Diagnostic Res. 2021:31-34.
13. Schwartz GG, Ballantyne CM, Barter PJ. Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome: Analysis of the dal-outcomes randomized clinical trial. JAMA Cardiol. 2018;3(2):164-168.
14. De Boer LM, Oorthuys AOJ, Wiegman A. Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis. Eur J Prev Cardiol. 2022;29(5):779-792.
15. Simony SB, Mortensen MB, Langsted A, Afzal S, Kamstrup PR, Nordestgaard BG, et al. Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study. Atherosclerosis. 2022;355(June):76-82.
16. Ashfaq F, Goel P, Moorthy N, Sethi R, Idrees Khan M, Idris M, et al. Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India. Sultan Qaboos Univ Med J. 2012 Nov; 12(4): 465–472.
17. Mackinnon LT, Laurel T, Lepre F. Effects of physical activity and diet on lipoprotein (a) European Journal of Sport Science, 2002;4(2):1-13.
18. Gulayin PE, Lozada A, Schreier L, Laura G, Graciela L, Rosana P, et al. Elevated Lipoprotein(a) prevalence and association with family history of premature cardiovascular disease. IJC Hear Vasc. 2022; 42:79-87.
19. Nasri H. Association of Serum Lipoprotein (a) with Hypertension in Diabetic Patients
. Saudi j kidney Dis Transpl. 2008;19(3):420-427.
20. El Kersh AM, Reda AA, Hadad MG, Elsharnoubi KH. Correlation between SYNTAX Score and Pattern of Risk Factors in Patients Referred for Coronary Angiography, Menoufia University. World J Cardiovasc Dis. 2018;08(08):431-439.
21. Tofaha HM, Salam MS. Prevalence and pattern of coronary artery disease in diabetic patients with cardiomyopathy. Egypt J Hosp Med. 2021;83(1):1183-1188.
22. Nabati M, Moosazadeh M. Correlation between overweightness and the extent of coronary atherosclerosis among the South Caspian population. BMC Cardiovasc Disord.2020;20(1):1-11.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Redwan Jaza Abdalwahid, Muzafar Abdulrahman Habeeb, Dana Hama-Baqi Mohammed-Saeed

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)










